Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
The following trial has been reported on the use of beta-interferon in progressive multiple sclerosis:
Beta-interferon is licensed in Europe for treatment of secondary progressive MS.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page